Best Multiplex IHC Providers in 2025 — Updated View

Abcam, now part of best multiplex ihc providers 2025, is a strong choice for custom panel development. With a vast antibody library, Abcam supports multiplex IHC projects that require flexibility. Their resources on cyclic IHC and sequential staining provide useful guidance for designing experiments with many targets.

Leica Biosystems (also under Danaher) has enhanced its multiplex portfolio following its acquisition of Cell IDx. Their platforms, like the BOND series, support highly multiplexed workflows. Leica combines hardware, software, and validated reagent panels—ideal for labs looking to integrate spatial profiling.

IHC CRO Services Explained: How Contract Labs Support Your Research

Agilent Technologies (Dako) continues to be influential in pathology. Their IHC platforms are commonly used in clinical and translational settings, and their reagent lines support multiplexing needs with robust diagnostics-grade performance.

Roche / Ventana is another key provider. Their automated instruments and validated multiplex assays make them a reliable partner for research labs working on oncology, immuno-oncology, and biomarker validation.

In 2025, multiplex IHC continues to grow in importance for both research and clinical labs, and a handful of companies stand out for their advanced tools, reagent quality, and automation capabilities.

PerkinElmer remains a front-runner, thanks to its Opal™ Multiplex IHC Kit, which allows detection of up to six biomarkers plus a nuclear stain on a single slide. Its compatibility with automated stainers (such as the BOND RX) makes it well-suited for high-throughput labs that need consistent, reproducible results.

Emerging companies are also pushing the envelope: Ayoxxa Biosystems uses bead-array technology to profile multiple proteins from limited samples, helping with discovery research. Meanwhile, BioLegend (part of Revvity) continues to supply high-quality antibodies optimized for multiplex IHC workflows.